Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Current Treatment Options in Oncology|February 20, 2019
The Potential of Targeting P53 and HSP90 Overcoming Acquired MAPKi-Resistant MelanomaChi-Che Hsieh, Che-Hung ShenNanomedicine : Nanotechnology, Biology, and Medicine|May 14, 2026
Nanotechnology-based reformulation of AUY922 mitigates retinal toxicity and retains potent anti-tumor activityChi-Che Hsieh, Nai-Jung Chiang, Sin-Jie Wang, et al.Oncogenesis|September 27, 2024
DKK1 as a chemoresistant protein modulates oxaliplatin responses in colorectal cancerChi-Che Hsieh, Ting-Wei Li, Chun-Chun Li, et al.Stem Cell Reviews and Reports|October 13, 2025
Exosome Purification Strategy Influences the Regenerative Efficacy of Dental Pulp Stem Cell-Derived Exosomes in Bone RegenerationBorae Lee, Chia-Yi Hung, Yu-Ting Chien, et al.Cancer Immunology, Immunotherapy : CII|October 6, 2025
Suppression of STK11 induces expansion of polymorphonuclear myeloid-derived suppressive cells and activation of immune signaling in breast cancerTzu-Hui Wei, Chi-Che Hsieh, Zhu-Jun Loh, et al.Journal of Advanced Research|December 30, 2022
TRPM1 promotes tumor progression in acral melanoma by activating the Ca<sup>2+</sup>/CaMKIIδ/AKT pathwayChi-Che Hsieh, Yue-Chiu Su, Kuan-Ying Jiang, et al.Oncogenesis|November 21, 2025
ACSL6 modulates docosahexaenoic acid-induced cytotoxicity to potentiate chemotherapy response in colorectal and breast cancerI-Sung Chen, Chi-Che Hsieh, Chun-Chun Li, et al.Journal of Biomedical Science|July 24, 2021
AUY922 induces retinal toxicity through attenuating TRPM1Che-Hung Shen, Chi-Che Hsieh, Kuan-Ying Jiang, et al.Gastroenterology|February 25, 2010
Differentiation of pancreatic acinar cells to hepatocytes requires an intermediate cell typeSung-Yu Wu, Chi-Che Hsieh, Ruei-Ren Wu, et al.British Journal of Cancer|August 23, 2022
CHK2 activation contributes to the development of oxaliplatin resistance in colorectal cancerChi-Che Hsieh, Sen-Huei Hsu, Chih-Yu Lin, et al.Pageof 2